Nuclear Medicine and Molecular Imaging

The Korean Society of Nuclear Medicine (대한핵의학회)
권호 표지

Current Status and Future Perspective of Nuclear Cardiology

심장핵의학의 현황과 전망

  • Chung, June-Key (Department of Nuclear Medicine, Seoul National University College of Medicine)
  • 정준기 (서울대학교 의과대학 핵의학교실)
  • Published : 2009.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Coronary artery disease is on the rise over the world. Myocardial perfusion SPECT is a well established technique to detect coronary artery disease and to assess left ventricular function. In addition, it has the unique ability to predict the prognosis of the patients. Moreover, the application of ECC-gated images provided the quantitatve data and improved the accuracy. This approach has been proved to be cost-effective and suitable for the emerging economies as well as developed countries. However, the utilization of nuclear cardiology procedures vary widely considering the different countries and region of the world. Korea exits 2-3 times less utilization than Japan, and 20 times than the United States. Recently, with the emerging of new technology, namely cardiac CT, cardiac MR and stress echocardiography, the clinical usefulness of nuclear cardiology has been called in question and its role has been redefined. For the proper promotion of nuclear cardiology, special educations should be conducted since the nuclear cardiology has the contact points between nuclear medicine and cardiology. Several innovations are in horizon which will impact the diagnostic accuracy as well as imaging time and cost savings. Development of new tracers, gamma camera technology and hybrid systems will open the new avenue in cardiac imaging. The future of nuclear cardiology based on molecular imaging is very exciting. The newly defined biologic targets involving atherosclerosis and vascular vulnerability will allow the answers for the key clinical questions. Hybrid techniques including SPECT/CT indicate the direction in which clinical nuclear cardiology may be headed in the immediate future. To what extent nuclear cardiology will be passively absorbed by other modalities, or will actively incorporate other modalities, is up to the present and next generation of nuclear cardiologists.

Keywords

References

  1. Strauss HW, Zaret BL, Hurley PJ, Natarajan TK Pitt B. A scintiphotographic method for measuring left ventricular ejection fraction in man without cardiac catheterization. Am J Cardiol 1971;28:575-80 https://doi.org/10.1016/0002-9149(71)90100-7
  2. Wackers FJ Th. Third Annual Mario S. Verani, MD. Memorial lecture: the future of clinical nuclear cardiology. J Nucl Cardiol 2005;12:381-91 https://doi.org/10.1016/j.nuclcard.2005.05.004
  3. Marcassa C, Bax JJ, Bengel F, Hesse B, Petersen CL, Reyes E, et al. Clinical value, cost-effectiveness, and safety of myocardial perfusion scintigraphy: a position statement. Eur Heart J 2008;29:557-63 https://doi.org/10.1093/eurheartj/ehm607
  4. Kim KY, Koh CS, Lee M. Diagnostic validity of RI angiocardiography in cardiac diseases. Korean J Nucl Med 1972;6:21-39
  5. Chung J-K, Park SY, Ryu PY, Cho BY, Kim BK, Koh C-S. A study on the radionuclide cardiac angiography in the various heart diseases. Korean J Nucl Med 1979;13:7-14
  6. Zaret BL. Second Annual Mario S. Verani, MD, Memorial Lecture: nuclear cardiology, the next 10 years. J Nucl Cardiol 2004;11:393-407. https://doi.org/10.1016/j.nuclcard.2004.05.001
  7. Davies JR, Rudd JF, Fryer TD, Weissberg PL. Targeting the vulnerable plaque: the evolving role of nuclear imaging. J Nucl Cardiol 2005;12:234-46 https://doi.org/10.1016/j.nuclcard.2005.01.008
  8. Bacharach SL. The new-generation positron emission tomography/computed tomography scanners: implications for cardiac imaging. J Nucl Cardiol 2004;11:388-92 https://doi.org/10.1016/j.nuclcard.2004.04.008
  9. Parkash R, deKemp RA, Ruddy TD, Kitsikis A, Hart R, Beauchesne L, et al. Potential utility of rubidium-82 PET quantification in patients with 3-vessel coronary artery disease. J Nucl Cardiol 2004;11:440-9 https://doi.org/10.1016/j.nuclcard.2004.04.005
  10. Inubushi M, Tamaki M. Radionuclide reporter gene imaging for cardiac gene therapy. Eur J Nul Med Mol Imaging 2007;34(Suppl 1):S27-33 https://doi.org/10.1007/s00259-007-0438-x
  11. Kang WJ, Kang HJ, Kim HS, Chung JK, Lee MC, Lee DS. Tissue distribution of F-18 FDG labeled peripheral hematopoietic stem cells after intracoronary administration in patients with myocardial infarction. J Nucl Med 2008;47:1295-301